We report here a 47-year-old womanwith isolated adrenocorticotropin (ACTH) deficiency (IAD). She presented impaired renin-angiotensin-aldosterone (R-A-A) system and suppressed parathyroid hormone (PTH)-vitamin D system. She showedsevere hyponatremia due to secondary adrenocortical insufficiency, which was deteriorated by hypoaldosteronism. She also showed hyperphosphatemia and relative hypercalcemia with suppressed PTH-vitamin D axis. Moreover, she showed hypothyroidism, which was thought to be important to maintain normal Ca levels under secondary hypoadrenalism via decrease in bone resorption by T3. Replacement with glucocorticoid completely normalized PTH-vitamin D axis and R-A-A system. Thus, the present case implicates that severe adrenocortical deficiency due to IAD might affect both R-A-A system and PTH-vitamin D axis. These findings suggest that the ACTHcortisol axis has an important role in mineral metabolism invivo. (Internal Medicine 41: 561-565, 2002) 
Introduction
Isolated adrenocorticotropin (ACTH) deficiency (IAD) is a definite clinical entity first described by Steinberg et al (1) . Its symptomsare headache, nausea/vomiting, general fatigue, appetite loss, body weight loss, etc. Although the clinical manifestations of IADare variable and not specific, for the most part, they can be explained by secondary adrenocortical insufficiency.
Adrenocortical deficiency such as Addison's disease or panhypopituitarism is knownto cause remarkable hyponatremia, hypercalcemia and hyperphosphatemia (2, 3) . In adrenocortical insufficiency, hyponatremia could arise either from excess water retention due to decreased free water clearance or from a blunted response of mineralcorticoid, such as aldosterone, to hyponatremia, with salt loss (4) . On the other hand, Ca metabolism is mainly regulated by the parathyroid hormone (PTH)-vitamin D axis. Hypercalcemia is considered to be elicited by increased interstinal Ca absorption, decreased urinary excretion of Ca and increased Ca release from bone. These could be corrected by glucocorticoid (GC) replacement.
Wereport here that a case of IADpresenting with severe hyporeninemic hypoaldosteronism and suppressed PTH-vitamin D axis. She showed a very interesting endocrinological disorder affecting the Na, Ca metabolism.
Case Report
A 47-year-old womanwithout a remarkable prior medical history visited medical clinic complaining of sore throat, nausea, general fatigue, appetite loss, and weight loss on December 27, 1994. The initial evaluation revealed elevation of acute phase reactants (WBC10,300/jil, CRP5.3 mg/dl), severe anemia (Hb 9.5 mg/dl), hyponatremia and hypochloridemia (s-Na 121 mEq//, s-Cl 89 mEq//). As her symptoms worsened, she was admitted to another hospital for further evaluation. On admission, serum Na and Cl were very low. Treatment was initiated with saline hydration, leading to the improvement of almost all symptoms. Endocrinological tests revealed low plasma ACTHand serum cortisol levels, suggesting secondary adrenal insufficiency. Therefore, she was transferred to our hospital for further endocrinological examination. Onadmission, the level of consciousness was normal, but she appeared apathetic and pallid. Urinalysis and stool examination were normal. Hematological tests showed severe microcytic hypochromic anemia with mild eosinophilia. Blood and urine chemistries were as follows; alkaline phosphatase 99 IU/ml (100-290); lactate dehydrogenase 194 mU/ml (160-325); total protein 5.6 g/dl (6.3-8.8); albumin 3. serum osmolality 250 mOsm/kg H2O; urine osmolarity 221 mOsm/kg H2O; Na 129 mmol// and fractional excretion of sodium (FENa) 1.08%; urinary Ca excretion 76.5 mg/day. Plasma osteocalcin 6.8 ng/ml (2.5-13); intact-osteocalcin 4.0 ng/ml (2.5-13); calcitonin 26 pg/ml (27.5-48.4); bone mineral density evaluated by dual energy Xray absorptiometry showed total BMD 1.079 g/cm2, age matched 102%. Antibodies to pituitary and adrenal glands were negative. Magnetic resonance imaging of the pituitary gland and computerized tomogram of adrenal glands showed normal images.
Basal plasma ACTHand serum cortisol levels were not detected. Urinary excretions of 17-OHCSand 17-KS were 0.3 mg/day (1.9-6.1) and 0.5 mg/day (3.1-8.8), respectively. Plasma antidiuretic hormone (ADH) level was 1.4 pg/ml (0.3-3.5). As shown in Table 1 Impaired R-A-A and PTH-vitamin D System in IAD We performed standing and furosemide loading test (furosemide 40 mg, intravenous injection on standing position) before supplement of GCto investigate the cause of hyporeninemia (Table 1) . To eliminate the influence of hypoosmolarity and hyponatremia, serum Na level had been corrected by saline infusion for several days about 150-220 mEq/day to keep serum Na level within normal limits before the test. After the test, the patient orally received hydrocortisone (20 mg/day) until now. Her symptoms and anemia were gradually improved and her serum Na levels became normalized without saline infusion. Twoweeks after the initiation of hydrocortisone supplement, werepeated again the sametest to confirm the effect of hydrocortisone on R-A-A system (Table 1) . Endocrinological evaluation tests also showed abnormalities of PTH-vitamin D axis and thyroid function ( Table 2) . These preclinical impairments were recovered by GCsupplement. After improvement of signs and symptomsof IAD, the patient was discharged on a maintenance dose of hydrocortisone (20 mg/day) finally.
Discussion
IADis sometimes associated with dysfunction of adrenal, thyroid or other pituitary hormones, therefore, endocrinological disorders in IAD are variable and non-specific, and IAD patients showvarious symptoms. Thepresent case also complained of nausea, general fatigue and hypotension, which are often observed in IADpatients. These symptomsare mainly due to hyponatremia, that is considered to be induced by several mechanisms.
First, the increase in urinary Na excretion should be mentioned. Deficit of mineralcorticoid-like effect of GCdirectly leads to a decrease in tubular Na reabsorption. In addition, GC deficiency causes hypoaldosteronism via a decrease in the synthesis of renin substrate in the liver, consequently leading to marked urinary Na excretion. Furthermore, a previous report has indicated that hydrocortisone supplement significantly decrease urinary Na excretion (5). These findings indicate that deficiency of both GCand aldosterone synergistically increases urinary Na excretion, and deteriorates hyponatremia. Impaired free water clearance is observed in IADpatients. Hypoaldosteronism decreases the glomerular filtration rate. Somerecent studies indicated that the synthesis ofADHin the hypothalamus and its secretion from the posterior pituitary gland are under inhibitory control by GCs (6) . Therefore, GC deficiency induces inappropriate secretion of ADH(SIADH), and augments volume expansion, leading to suppression of plasma renin activity (PRA) and aldosterone secretion. These findings support that SIADH in IADcauses water retention as well as continuous Na loss via hyporeninemic hypoaldosteronism, deteriorating hyponatremia.
The present case showedsevere hyponatremia due to both hyporeninemic hypoaldosteronism and SIADH. Both FENa and urine osmolarity were relatively high compared with serum Na concentration and osmolarity. Moreover, plasma ADHlevel was also relatively high, implying that SIADHdeteriorated hyponatremia. These data indicated that Na losing and water retention due to glucocorticoid deficiency elicited severe hyponatremia. GCreplacement promptly increased the serum Na concentration and PRA, and made the ADHlevel suitable for serumNaconcentration. Albeit hypercalcemia occasionally occures in patients with IAD, its mechanism still remains unclear. It is generally accepted that GCsdecrease the net intestinal Ca absorption and renal Ca reabsorption (7). Vasikaran et al also described reduced renal excretion of Ca due to a reduction in Ca delivery to the glomerulus and increased proximal tubular reabsorption in the presence of GC deficiency (8) . Physiological amounts of GCsare neccesary for the acquisition and preservation of the differentiated state in osteoblasts (9) . These findings indicate that the etiology of hypercalcemia associated with GC deficiency is composed of increased intestinal Ca absorption, decreased renal excretion of Ca and increased Ca release from bone. andpatient's bonemineral density evaluated by dual energy X-ray absorptiometry was normal. Thoughthese findings including restrained PTH-1,25-(OH)2D3axis do not necessarily suggest that bone absorption is positively suppressed, impaired excretions of Caand phosphate wouldgreatly influence the increase in serumCalevel. Despite the lowserumlevels of 1,25-(OH)2D3and intact PTHin this patient, the serumCalevel wasnear the upper normal limit. Thediscrepancy betweenserum Ca level and these hormonelevels couldbe interpreted as follows; secretion of these hormoneswassuppressedby the relatively high level of serumCa. However,this patient never developedhypercalcemiaduring the courseof admission.It has beenshownthat thyroidhormones stimulateboneresorptionin tissue culture (10) . It wasalso describedthat correction of hypothyroidism with thyroxine precipitates hypercalcemia (1 1). In addition, it has been shownthat adrenalectomizeddogs develop hypercalcemia only in the presence of thyroid gland (12) . The present patient showedtypical hypothyroidism (Table 2) . IADis well known to be accompanied by mildor moderatehypothyroidism without autoimmune thyroiditis, whichis reversible and showsgood response to GCreplacementtherapy, and this is also the case in this patient. Thesefindings mayindicate that there is an ingeniousmechanism to avoidincreasesin the serumCalevel and impairment of this mechanism induceshypercalcemia.
Thepresent case showedimpairment of R-A-A axis and PTH-vitaminD axis. It was shownthat PTHadministration producesa consistent rise in PRAin the dog (13). Grant and colleguesshowedthat angiotensinII infusion producesan increase in serumPTHlevel and a significant decrease in the serum ionized Ca level (14) . They further demonstrated that PTHinfusion significantly decreases the tubular reabsorption of phosphate. Impairmentof the hormonesystemregulating Naand Cahomeostasisaggravates each pathophysiological state synergisticaly. Theserelationships betweenR-A-Aaxis and PTH-vitaminD axis suggest a mechanismunderlyingthe close associationof Caand Nametabolism. Thepresentcase showedhyporeninemichypoaldosteronism,indicating that her plasmaangiotensin II concentrationwasalso low. Although angiotensinII decreasesserumCaconcentrationessentially, serumCa level in this case might be high becauseof lowangiotensin II concentration. Moreover,lowPTHconcentration wouldbe one of factors whichaggravetedlowPRA. Hereinwereported a case of IADwith impairedR-A-A systemand PTH-vitamin D axis secondarydue to adrenocortical insufficiency. This patient showedsevere hyponatremiainduced by impaired R-A-Asystem, but no hypercalcemia, which may be ascribed to GCdeficiency elicited-impaired PTH-vitaminDaxis. Hypothyroidism is also consideredto contributeto this phenomenon. Thetwomajorendocrinologicalaxes sup-Impaired R-A-A and PTH-vitamin D System in IAD pressed by adrenocortical insufficiency aggravate each pathophysiological statement synergisticly. These findings suggested that ACTH-cortisol axis has an important role in mineral metabolism in vivo.
